Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer

Silvana Chiara, M. Orsatti, Paola Franzone, D. Scarpati, Milena Bruzzone, L. Repetto, V. Vitale, P. F. Conte, R. Rosso

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Thirty advanced ovarian cancer patients have been treated with sequential multimodality treatment including primary surgery, cisplatin or carboplatin-based polichemotherapy, second-look laparotomy followed by abdominopelvic irradiation (moving strip or open-field technique). Toxicity related to the combined treatment was acceptable: only three patients failed to complete and two patients delayed the prescribed course of radiotherapy because of acute myelosuppression or gastroenteric disturbances. One patient without evidence of disease required laparotomy for bowel obstruction one month after completion of radiotherapy. No other chronic toxicity of clinical significance has been observed. Actuarial three-year survival significantly correlated with residual disease at the start of radiotherapy: no residuum, 100%, microscopic disease, 52%;

Original languageEnglish
Pages (from-to)340-344
Number of pages5
JournalClinical Oncology
Volume3
Issue number6
DOIs
Publication statusPublished - 1991

Fingerprint

Ovarian Neoplasms
Radiotherapy
Drug Therapy
Laparotomy
Carboplatin
Cisplatin
Survival
Therapeutics

Keywords

  • Abdominopelvic radiotherapy
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Chiara, S., Orsatti, M., Franzone, P., Scarpati, D., Bruzzone, M., Repetto, L., ... Rosso, R. (1991). Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. Clinical Oncology, 3(6), 340-344. https://doi.org/10.1016/S0936-6555(05)80590-4

Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. / Chiara, Silvana; Orsatti, M.; Franzone, Paola; Scarpati, D.; Bruzzone, Milena; Repetto, L.; Vitale, V.; Conte, P. F.; Rosso, R.

In: Clinical Oncology, Vol. 3, No. 6, 1991, p. 340-344.

Research output: Contribution to journalArticle

Chiara, S, Orsatti, M, Franzone, P, Scarpati, D, Bruzzone, M, Repetto, L, Vitale, V, Conte, PF & Rosso, R 1991, 'Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer', Clinical Oncology, vol. 3, no. 6, pp. 340-344. https://doi.org/10.1016/S0936-6555(05)80590-4
Chiara, Silvana ; Orsatti, M. ; Franzone, Paola ; Scarpati, D. ; Bruzzone, Milena ; Repetto, L. ; Vitale, V. ; Conte, P. F. ; Rosso, R. / Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer. In: Clinical Oncology. 1991 ; Vol. 3, No. 6. pp. 340-344.
@article{2facf06f5dbf42a5b5a8d7ac0c74a7ff,
title = "Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer",
abstract = "Thirty advanced ovarian cancer patients have been treated with sequential multimodality treatment including primary surgery, cisplatin or carboplatin-based polichemotherapy, second-look laparotomy followed by abdominopelvic irradiation (moving strip or open-field technique). Toxicity related to the combined treatment was acceptable: only three patients failed to complete and two patients delayed the prescribed course of radiotherapy because of acute myelosuppression or gastroenteric disturbances. One patient without evidence of disease required laparotomy for bowel obstruction one month after completion of radiotherapy. No other chronic toxicity of clinical significance has been observed. Actuarial three-year survival significantly correlated with residual disease at the start of radiotherapy: no residuum, 100{\%}, microscopic disease, 52{\%};",
keywords = "Abdominopelvic radiotherapy, Ovarian cancer",
author = "Silvana Chiara and M. Orsatti and Paola Franzone and D. Scarpati and Milena Bruzzone and L. Repetto and V. Vitale and Conte, {P. F.} and R. Rosso",
year = "1991",
doi = "10.1016/S0936-6555(05)80590-4",
language = "English",
volume = "3",
pages = "340--344",
journal = "Clinical Oncology",
issn = "0936-6555",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancer

AU - Chiara, Silvana

AU - Orsatti, M.

AU - Franzone, Paola

AU - Scarpati, D.

AU - Bruzzone, Milena

AU - Repetto, L.

AU - Vitale, V.

AU - Conte, P. F.

AU - Rosso, R.

PY - 1991

Y1 - 1991

N2 - Thirty advanced ovarian cancer patients have been treated with sequential multimodality treatment including primary surgery, cisplatin or carboplatin-based polichemotherapy, second-look laparotomy followed by abdominopelvic irradiation (moving strip or open-field technique). Toxicity related to the combined treatment was acceptable: only three patients failed to complete and two patients delayed the prescribed course of radiotherapy because of acute myelosuppression or gastroenteric disturbances. One patient without evidence of disease required laparotomy for bowel obstruction one month after completion of radiotherapy. No other chronic toxicity of clinical significance has been observed. Actuarial three-year survival significantly correlated with residual disease at the start of radiotherapy: no residuum, 100%, microscopic disease, 52%;

AB - Thirty advanced ovarian cancer patients have been treated with sequential multimodality treatment including primary surgery, cisplatin or carboplatin-based polichemotherapy, second-look laparotomy followed by abdominopelvic irradiation (moving strip or open-field technique). Toxicity related to the combined treatment was acceptable: only three patients failed to complete and two patients delayed the prescribed course of radiotherapy because of acute myelosuppression or gastroenteric disturbances. One patient without evidence of disease required laparotomy for bowel obstruction one month after completion of radiotherapy. No other chronic toxicity of clinical significance has been observed. Actuarial three-year survival significantly correlated with residual disease at the start of radiotherapy: no residuum, 100%, microscopic disease, 52%;

KW - Abdominopelvic radiotherapy

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=0026248669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026248669&partnerID=8YFLogxK

U2 - 10.1016/S0936-6555(05)80590-4

DO - 10.1016/S0936-6555(05)80590-4

M3 - Article

C2 - 1742234

AN - SCOPUS:0026248669

VL - 3

SP - 340

EP - 344

JO - Clinical Oncology

JF - Clinical Oncology

SN - 0936-6555

IS - 6

ER -